# GRAFAPEX
> **NDA214759** · New Drug Application · Sponsor: MEDEXUS · Approved 2025-01-21
## Drug
- **FDA Application Number:** NDA214759
- **Application type:** New Drug Application
- **Brand name:** GRAFAPEX
- **Generic name:** TREOSULFAN
- **Active ingredients:** TREOSULFAN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MEDEXUS
- **Manufacturer:** Medexus Pharma, Inc.
- **First approval:** 2025-01-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214759)
---
*AI Analytics · CC0 1.0*